$1.51 Billion is the total value of QVT Financial LP's 59 reported holdings in Q4 2012. The portfolio turnover from Q3 2012 to Q4 2012 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2012 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MAKEMYTRIP LIMITED MAURITIUS | 41 | Q2 2024 | 6.2% |
NEW YORK TIMES CO | 37 | Q2 2024 | 2.6% |
SAREPTA THERAPEUTICS INC | 35 | Q2 2024 | 1.1% |
BIOMARIN PHARMACEUTICAL INC | 35 | Q2 2024 | 0.5% |
GOLDMAN SACHS GROUP INC | 33 | Q2 2024 | 5.4% |
ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
ACADIA PHARMACEUTICALS INC | 31 | Q2 2024 | 0.2% |
NEXSTAR MEDIA GROUP INC | 29 | Q2 2024 | 3.4% |
IOVANCE BIOTHERAPEUTICS INC | 29 | Q2 2024 | 5.5% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Roivant Sciences Ltd. | March 07, 2024 | 66,719,779 | 8.3% |
MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-09-26 |
SC 13D/A | 2024-09-03 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
4 | 2024-03-07 |
SC 13G/A | 2024-03-07 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
4 | 2023-10-02 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.